CoChat

Ketamine Metabolites Enantioselectively Decrease Intracellular D-Serine Concentrations in PC-12 Cells

Open access
Singh, Nagendra S., Rutkowska, Ewelina, Plazinska, Anita, Khadeer, Mohammed, Moaddel, Ruin, Jozwiak, Krzysztof, Bernier, Michel, Wainer, Irving W. · 2016 · PLOS ONE

The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.

Abstract

D-Serine is an endogenous NMDA receptor co-agonist that activates synaptic NMDA receptors modulating neuronal networks in the cerebral cortex and plays a key role in long-term potentiation of synaptic transmission. D-serine is associated with NMDA receptor neurotoxicity and neurodegeneration and elevated D-serine concentrations have been associated with Alzheimer's and Parkinsons' diseases and amyotrophic lateral sclerosis. Previous studies have demonstrated that the ketamine metabolites (rac)-dehydronorketamine and (2S,6S)-hydroxynorketamine decrease intracellular D-serine concentrations in a concentration dependent manner in PC-12 cells. In the current study, PC-12 cells were incubated with a series of ketamine metabolites and the IC50 values associated with attenuated intracellular D-serine concentrations were determined. The results demonstrate that structural and stereochemical features of the studied compounds contribute to the magnitude of the inhibitory effect with (2S,6S)-hydroxynorketamine and (2R,6R)-hydroxynorketamine displaying the most potent inhibition with IC50 values of 0.18 ± 0.04 nM and 0.68 ± 0.09 nM. The data was utilized to construct a preliminary 3D-QSAR/pharmacophore model for use in the design of new and more efficient modulators of D-serine.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0149499

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig 1 The structures of the compounds used in this study.
Fig 1 The structures of the compounds used in this study.CC0 · PubMed Central
Fig 2 Effect of (2R,6R)-hydroxynorketamine (HNK) on the levels of serine racemase protein in PC-12 cells. Cells were treated with various concentrations of HNK for 36 h and then total cell lysates were prepared for Western blot analysis. Top panel: representative immunoblot of monomeric serine racemase (m-SR; 36-kilodalton band). The blot was reprobed for β-actin, which was used as loading control. Bottom panel: relative levels of m-SR after quantification and normalization with β-actin. Bars represent the means ± SD of three independent experiments. * P< 0.05 and ** P< 0.01 as compared with control cells.
Fig 2 Effect of (2R,6R)-hydroxynorketamine (HNK) on the levels of serine racemase protein in PC-12 cells. Cells were treated with various concentrations of HNK for 36 h and then total cell lysates were prepared for Western blot analysis. Top panel: representative immunoblot of monomeric serine racemase (m-SR; 36-kilodalton band). The blot was reprobed for β-actin, which was used as loading control. Bottom panel: relative levels of m-SR after quantification and normalization with β-actin. Bars represent the means ± SD of three independent experiments. * P< 0.05 and ** P< 0.01 as compared with control cells.CC0 · PubMed Central
Fig 3 CoMFA models derived from the potency (determined as IC50 value) of ketamine metabolites on intracellular D-Ser concentrations. Nine compounds were considered in this study. The inclusion of (R)-norKet (A); (2R,6R)-HNK (B) and (2R,6S)-HNK (C) are depicted.
Fig 3 CoMFA models derived from the potency (determined as IC50 value) of ketamine metabolites on intracellular D-Ser concentrations. Nine compounds were considered in this study. The inclusion of (R)-norKet (A); (2R,6R)-HNK (B) and (2R,6S)-HNK (C) are depicted.CC0 · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 33 references

Cited by

See all 24

Metadata

Authors
Singh, N. S., Rutkowska, E., Plazinska, A., Khadeer, M., Moaddel, R., Jozwiak, K., Bernier, M., & Wainer, I. W.
Affiliations
  • National Institutes of Health (US)
  • Medical University of Lublin (PL)
Corresponding author
Wainer, Irving W.
Venue
PLOS ONE
Published
2016-04-20
Volume
11
Issue
4
Pages
e0149499
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2339134523
Cited by
23
References
33
Citations by year
2025: 1 · 2024: 1 · 2023: 1 · 2022: 3 · 2021: 4 · 2020: 2 · 2018: 6 · 2017: 4 · 2016: 1
FWCI
2.42
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, public-domain)
  • PubMed Central (publishedVersion, public-domain)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Fundacja na rzecz Nauki Polskiej
  • National Institutes of Health
  • National Institute on Aging
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Keywords
ketamine metabolites, D-serine, enantiomers, hydroxynorketamine, dehydronorketamine, NMDA receptor co-agonist, PC12 cells, stereochemistry, 3D-QSAR, pharmacophore model, neurodegeneration
MeSH terms
Animals, Ketamine, Models, Molecular, Serine, Stereoisomerism, Blotting, Western, Minor Histocompatibility Antigens, PC12 Cells, Protein Transport, Amino Acid Transport System ASC, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Ketamine Metabolites Enantioselectively Decrease Intracellular D-Serine Concentrations in PC-12 Cells. https://app.cochat.ai/papers/10.1371/journal.pone.0149499
The paper
Singh, N. S., Rutkowska, E., Plazinska, A., Khadeer, M., Moaddel, R., Jozwiak, K., Bernier, M., & Wainer, I. W. (2016). Ketamine Metabolites Enantioselectively Decrease Intracellular D-Serine Concentrations in PC-12 Cells. PLOS ONE. https://doi.org/10.1371/journal.pone.0149499

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.